SCHEMBL19397359

SCHEMBL19397359

CC1(C)c2ccccc2-c2cccc(-c3ccc(-c4cc(-c5ccc(-c6ccccc6)cc5)nc(-c5ccc(-c6ccncc6)cc5)n4)cc3)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 9/20 0.42
MEN1 O00255 8/20 0.42
KMT2A Q03164 8/20 0.42
ALDH1A1 P00352 8/20 0.42
KDM4E B2RXH2 5/20 0.42
LMNA P02545 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
RECQL P46063 1/20 0.42
PDK2 Q15119 1/20 0.41
HPGD P15428 6/20 0.41
NTSR1 P30989 1/20 0.41
GLA P06280 1/20 0.40
SQOR Q9Y6N5 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19397312 1.00 MAPT (0.42) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL19397586 0.95 PDK2 (0.40) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL19397543 0.95 PDK2 (0.40) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL19397429 0.95 MEN1 (0.41) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL19397472 0.95 MEN1 (0.41) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL22059014 0.92 MEN1 (0.47) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL26937620 0.92 MEN1 (0.47) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL25009041 0.90 MEN1 (0.45) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL25009046 0.90 MEN1 (0.45) MAPTMEN1KMT2AALDH1A1KDM4E
SCHEMBL25008541 0.90 MEN1 (0.45) MAPTMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2020-03-03 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME E-RAY OPTOELECTRONICS TECHNOLOGY CO., LTD. (TW) 2017-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580995-B2 Compounds for organic electroluminescent components and organic electroluminescent devices using the same C1S, AOC2, L1CAM MAPT 3242/4885MEN1 682/4885KMT2A 3347/4885
US-20170279054-A1 COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT COMPONENTS AND ORGANIC ELECTROLUMINESCENT DEVICES USING THE SAME L1CAM, C1S, F10 MAPT 3912/4885MEN1 509/4885KMT2A 3322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.